{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:04:14Z","timestamp":1792760654362,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116530","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:49:27Z","timestamp":1775198967000},"page":"116530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Next 5\u00a0years in autoimmunity: predictive diagnostics, immune signatures, and personalized immune therapy"],"prefix":"10.1016","volume":"179","author":[{"given":"Afreen","family":"Usmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Aftab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gowri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Faiyazuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-025-03490-2","article-title":"Impact of disease duration on systemic clinical profile in Sjogren\u2019s syndrome","volume":"27","author":"Wu","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2026.116530_bb0010","article-title":"Artificial intelligence for predicting treatment responses in autoimmune rheumatic diseases: advancements, challenges, and future perspectives","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2026.116530_bb0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/nu18040639","article-title":"Air pollution, asthma and diet: from mechanisms to prevention strategies","volume":"18","author":"Carvalho","year":"2026","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.intimp.2026.116530_bb0025","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review","volume":"16","author":"Muteeb","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2026.116530_bb0030","article-title":"Artificial intelligence in autoimmune diseases: a bibliometric exploration of the past two decades","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116530_bb0035","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","author":"Choi","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41540-024-00450-5","article-title":"Immune digital twins for complex human pathologies: applications, limitations, and challenges","volume":"10","author":"Niarakis","year":"2024","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.intimp.2026.116530_bb0045","doi-asserted-by":"crossref","first-page":"102035","DOI":"10.1016\/j.toxrep.2025.102035","article-title":"Advancing precision medicine: uncovering biomarkers and strategies to mitigate immune-related adverse events in immune checkpoint inhibitors therapy","volume":"14","author":"Nityashree","year":"2025","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.intimp.2026.116530_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1112858","article-title":"The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes","volume":"14","author":"Roep","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0055","series-title":"Infection and autoimmunity","first-page":"61","article-title":"Epitope spreading in autoimmune diseases","author":"Venkatesha","year":"2024"},{"key":"10.1016\/j.intimp.2026.116530_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109807","article-title":"Profiling of mouse and human liver diseases identifies targets for therapeutic treatment of autoimmune hepatitis","volume":"256","author":"Centa","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.11.002","article-title":"Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity","volume":"98","author":"Molano-Gonz\u00e1lez","year":"2019","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.intimp.2026.116530_bb0070","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/biomedicines13102472","article-title":"Interferons in autoimmunity: from loss of tolerance to chronic inflammation","volume":"13","author":"Mihaescu","year":"2025","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.intimp.2026.116530_bb0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/09612033221102575","article-title":"Role of interleukin-6 and interferon-\u03b1 in systemic lupus erythematosus: a case\u2013control study and meta-analysis","volume":"31","author":"Pattanaik","year":"2022","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.intimp.2026.116530_bb0080","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/metabo10120492","article-title":"Integrative metabolomics to identify molecular signatures of responses to vaccines and infections","volume":"10","author":"Diray-Arce","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13075-024-03423-5","article-title":"Integrated multi-omics revealed that dysregulated lipid metabolism played an important role in RA patients with metabolic diseases","volume":"26","author":"Zhu","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2026.116530_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255664","article-title":"Local and systemic effects of microbiome-derived metabolites","volume":"23","author":"Spivak","year":"2022","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.116530_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185217","article-title":"Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis","volume":"135","author":"Inamo","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2026.116530_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/ijms26041773","article-title":"Microbiota and inflammatory markers: a review of their interplay, clinical implications, and metabolic disorders","volume":"26","author":"Pe\u00f1a-Dur\u00e1n","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41746-022-00610-z","article-title":"Building digital twins of the human immune system: toward a roadmap","volume":"5","author":"Laubenbacher","year":"2022","journal-title":"npj Digit. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-025-01435-7","article-title":"Digital twins as global learning health and disease models for preventive and personalized medicine","volume":"17","author":"Li","year":"2025","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2026.116530_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105743","article-title":"A probiotic approach identifies a Treg-centred immunoregulation via modulation of gut microbiota metabolites in people with multiple sclerosis and healthy individuals","volume":"116","author":"Tr\u00e4ger","year":"2025","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.intimp.2026.116530_bb0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/bios15060351","article-title":"Non-invasive wearables in inflammation monitoring: from biomarkers to biosensors","volume":"15","author":"Wu","year":"2025","journal-title":"Biosensors"},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2023.100473","article-title":"Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases","volume":"4","author":"Yasumizu","year":"2024","journal-title":"Cell Genomics"},{"key":"10.1016\/j.intimp.2026.116530_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1258013","article-title":"Combination of multiple omics techniques for a personalized therapy or treatment selection","volume":"14","author":"Massa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2022.867950","article-title":"T-cell aging-associated phenotypes in autoimmune disease","volume":"3","author":"Zhao","year":"2022","journal-title":"Front. Aging"},{"issue":"6681","key":"10.1016\/j.intimp.2026.116530_bb0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.adf8531","article-title":"The transcription factor ZEB2 drives the formation of age-associated B cells","volume":"383","author":"Dai","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12016-025-09021-w","article-title":"Age-associated B cells in autoimmune diseases: pathogenesis and clinical implications","volume":"68","author":"Xie","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.intimp.2026.116530_bb0150","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41590-023-01722-8","article-title":"A pairwise cytokine code explains the organism-wide response to sepsis","volume":"25","author":"Takahama","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.102984","article-title":"Tissue-resident macrophages\u2014early passengers or drivers in the tumor niche?","volume":"83","author":"Vogel","year":"2023","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-024-02050-5","article-title":"Tissue-resident immune cells: from defining characteristics to roles in diseases","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116530_bb0170","series-title":"Seminars in immunopathology","article-title":"Tissue-resident memory T cells in the kidney","author":"Asada","year":"2022"},{"issue":"3","key":"10.1016\/j.intimp.2026.116530_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12016-022-08951-z","article-title":"A summary on the genetics of systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and Sj\u00f6gren\u2019s syndrome","volume":"64","author":"Ortiz-Fernandez","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.intimp.2026.116530_bb0180","article-title":"Single cell spatial transcriptomic profiling of childhood-onset lupus nephritis reveals complex interactions between kidney stroma and infiltrating immune cells","author":"Danaher","year":"2023","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40259-023-00635-0","article-title":"Molecular engineering of interleukin-2 for enhanced therapeutic activity in autoimmune diseases: LM Tomasovic et al","volume":"38","author":"Tomasovic","year":"2024","journal-title":"BioDrugs"},{"issue":"4","key":"10.1016\/j.intimp.2026.116530_bb0190","first-page":"1211","article-title":"Mechanistic insights into peripheral immune tolerance pathways: the role of forkhead box protein P3 and cytotoxic T-lymphocyte associated protein 4 in inborn errors of immunity and therapeutic perspectives","volume":"3","author":"Ujjan","year":"2025","journal-title":"Multidisc. Surg. Res. Ann."},{"issue":"4","key":"10.1016\/j.intimp.2026.116530_bb0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/1744666X.2025.2465406","article-title":"Toward a personalized therapy of still\u2019s disease based on immunologic endotypes: a narrative review","volume":"21","author":"Chen","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaci.2024.09.020","article-title":"JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity","volume":"155","author":"Samra","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41392-024-01934-w","article-title":"The JAK-STAT pathway: from structural biology to cytokine engineering","volume":"9","author":"Lv","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2026.116530_bb0210","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s13346-022-01233-3","article-title":"Nanomaterials for antigen-specific immune tolerance therapy","volume":"13","author":"Park","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.116530_bb0215","first-page":"5219","article-title":"Tolerogenic nano-\/microparticle vaccines for immunotherapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.116530_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864403","article-title":"Nanoparticles for inducing antigen-specific T cell tolerance in autoimmune diseases","volume":"13","author":"Benne","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/9783527838394.ch7","article-title":"mRNA vaccination for induction of immune tolerance against autoimmune disease","author":"Gissler","year":"2025","journal-title":"Trends mRNA Vacc. Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.116530_bb0230","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/j.ymthe.2024.09.019","article-title":"Synergistic integration of mRNA-LNP with CAR-engineered immune cells: pioneering progress in immunotherapy","volume":"32","author":"Chen","year":"2024","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2026.116530_bb0235","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1039\/D3NR05635J","article-title":"Development of polypeptide-based materials toward messenger RNA delivery","volume":"16","author":"Zhao","year":"2024","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0240","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70068","article-title":"Functional and metabolic heterogeneity of dendritic cells in self-tolerance and autoimmunity","volume":"336","author":"Chen","year":"2025","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2026.116530_bb0245","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.3390\/ijms24098313","article-title":"Immunosuppressive polymeric nanoparticles targeting dendritic cells alleviate lupus disease in Fcgr2b\u2212\/\u2212 mice by mediating antigen-specific immune tolerance","volume":"24","author":"Khiewkamrop","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116530_bb0250","first-page":"42","article-title":"B cell-directed therapy in autoimmunity","author":"Abeles","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12016-024-08984-6","article-title":"B-cell receptor repertoire: recent advances in autoimmune diseases","volume":"66","author":"Wang","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.intimp.2026.116530_bb0260","series-title":"Seminars in Arthritis and Rheumatism","article-title":"Beyond the surface-autoreactive B cells in human autoimmune diseases","author":"Scherer","year":"2024"},{"key":"10.1016\/j.intimp.2026.116530_bb0265","first-page":"69","article-title":"Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee","author":"Greco","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.intimp.2026.116530_bb0270","article-title":"TCR and BCR repertoire analysis reveals distinct signatures between benign and malignant ovarian tumors","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s44342-024-00034-z","article-title":"Comprehensive analysis of TCR and BCR repertoires: insights into methodologies, challenges, and applications","volume":"23","author":"Seo","year":"2025","journal-title":"Genom. Inf."},{"key":"10.1016\/j.intimp.2026.116530_bb0280","series-title":"Microbiota Profiling for Precision Medicine: Biomarker-Targeted Drug Delivery Strategies","first-page":"97","article-title":"Immunomodulatory effects of microbiome-derived therapies","author":"Ghosh","year":"2025"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.15352","article-title":"Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment","volume":"1548","author":"Mkilima","year":"2025","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"29","key":"10.1016\/j.intimp.2026.116530_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.eng.2023.04.007","article-title":"Biosynthesis and immunological evaluation of a dual-antigen nanoconjugate vaccine against Brucella melitensis","author":"Huang","year":"2023","journal-title":"Engineering"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s44337-024-00029-3","article-title":"The potential of immunomodulators in shaping the future of healthcare","volume":"1","author":"Sharma","year":"2024","journal-title":"Disc. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116530_bb0300","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/jcm14051735","article-title":"Precision medicine in rheumatology: the role of biomarkers in diagnosis and treatment optimization","volume":"14","author":"Colina","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.116530_bb0305","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ard.2025.06.150","article-title":"POS0791 soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE","volume":"84","author":"Dreveton","year":"2025","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2023.100444","article-title":"Predicting patient outcomes after treatment with immune checkpoint blockade: a review of biomarkers derived from diverse data modalities","volume":"4","author":"Liu","year":"2024","journal-title":"Cell Genomics"},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0315","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12016-021-08918-6","article-title":"The role of autoantibody testing in modern personalized medicine","volume":"63","author":"Kayser","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0320","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41467-023-44512-4","article-title":"Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis","volume":"15","author":"Middha","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41746-024-01043-6","article-title":"Informing immunotherapy with multi-omics driven machine learning","volume":"7","author":"Li","year":"2024","journal-title":"npj Digit. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116530_bb0330","doi-asserted-by":"crossref","first-page":"103837","DOI":"10.1016\/j.autrev.2025.103837","article-title":"Dual B-cell targeting in systemic lupus erythematosus: the role of combined and sequential therapy with rituximab and Belimumab","volume":"24","author":"Frade-Sosa","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2026.116530_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1476859","article-title":"CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0340","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13075-024-03330-9","article-title":"Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning","volume":"26","author":"Lin","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"16","key":"10.1016\/j.intimp.2026.116530_bb0345","doi-asserted-by":"crossref","first-page":"8612","DOI":"10.3390\/ijms25168612","article-title":"Anti-TCP1 antibody is a potential biomarker for diagnosing systemic lupus erythematosus","volume":"25","author":"Lee","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.116530_bb0350","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13075-014-0489-x","article-title":"Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome uncovered through gene expression meta-analysis","volume":"16","author":"Toro-Dom\u00ednguez","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0355","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13040-021-00284-5","article-title":"Machine learning approaches for the genomic prediction of rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Chung","year":"2021","journal-title":"BioData Mining"},{"issue":"12","key":"10.1016\/j.intimp.2026.116530_bb0360","article-title":"A rare case of rhupus syndrome with systemic involvement: a case report and literature review","volume":"14","author":"Dairi","year":"2022","journal-title":"Cureus"},{"issue":"21","key":"10.1016\/j.intimp.2026.116530_bb0365","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.3390\/ijms262110788","article-title":"Unraveling type 1 diabetes: integrating microbiome, metabolomics, and immunomodulation for next-generation therapies","volume":"26","author":"de Groen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116530_bb0370","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/cimb47050321","article-title":"The potential use of digital twin technology for advancing CAR-T cell therapy","volume":"47","author":"Aghamiri","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116530_bb0375","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/biomedicines12071496","article-title":"Navigating challenges and opportunities in multi-omics integration for personalized healthcare","volume":"12","author":"Mohr","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.116530_bb0380","series-title":"Precision medicine and artificial intelligence","first-page":"189","article-title":"Development of multi-omics approach in autoimmune diseases","author":"Choi","year":"2021"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/acsbiomaterials.3c01247","article-title":"Harnessing nanovaccines for effective immunization\u2013a special concern on COVID-19: facts, fidelity, and future prospective","volume":"10","author":"Gholap","year":"2023","journal-title":"ACS Biomater Sci. Eng."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0390","first-page":"21","article-title":"AI-enhanced health informatics frameworks for predicting infectious disease outbreak dynamics using climate, mobility, and population immunization data integration","volume":"5","author":"Abi","year":"2023","journal-title":"IJMS"},{"issue":"10","key":"10.1016\/j.intimp.2026.116530_bb0395","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2026.116530_bb0400","series-title":"A Handbook of Artificial Intelligence in Drug Delivery","first-page":"1","article-title":"An overview of artificial intelligence in drug development","author":"Philip","year":"2023"},{"issue":"3","key":"10.1016\/j.intimp.2026.116530_bb0405","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08923973.2018.1437625","article-title":"CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis","volume":"40","author":"Safari","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0410","doi-asserted-by":"crossref","first-page":"54","DOI":"10.69936\/en11y0024","article-title":"Synthetic biology-enabled engineering of probiotics for precision and targeted therapeutic delivery applications","volume":"1","author":"Patra","year":"2024","journal-title":"Exon"},{"key":"10.1016\/j.intimp.2026.116530_bb0415","series-title":"Design and Processing of Green Materials: Exploring Sustainable Applications in Medical and Pharmaceuticals Sciences","first-page":"391","article-title":"Patents, clinical trials and dosage form based on biomaterials","author":"Shaikh","year":"2025"},{"issue":"4","key":"10.1016\/j.intimp.2026.116530_bb0420","doi-asserted-by":"crossref","first-page":"103154","DOI":"10.1016\/j.jiph.2026.103154","article-title":"Digital twin of Mycobacterium tuberculosis infection: integrating immune dynamics and pathogen adaptation for precision therapy","volume":"19","author":"Siddiqui","year":"2026","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41746-024-01402-3","article-title":"Challenges and opportunities for digital twins in precision medicine from a complex systems perspective","volume":"8","author":"De Domenico","year":"2025","journal-title":"npj Digit. Med."},{"issue":"7","key":"10.1016\/j.intimp.2026.116530_bb0430","article-title":"Medical digital twins: enabling precision medicine and medical artificial intelligence","volume":"7","author":"Sad\u00e9e","year":"2025","journal-title":"Lancet Digit. Health"},{"issue":"2","key":"10.1016\/j.intimp.2026.116530_bb0435","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-5193(05)80334-0","article-title":"The immune system as a neural network: a multi-epitope approach","volume":"150","author":"Vertosick","year":"1991","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.intimp.2026.116530_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.108804","article-title":"A systematic review of AI as a digital twin for prostate cancer care","volume":"268","author":"John","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"issue":"48","key":"10.1016\/j.intimp.2026.116530_bb0445","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1093\/eurheartj\/ehaa159","article-title":"The \u2018digital Twin\u2019 o enable the vision of precision cardiology","volume":"41","author":"Corral-Acero","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2026.116530_bb0450","article-title":"A comprehensive review of digital twin in healthcare in the scope of simulative health-monitoring","volume":"11","author":"Nadeem","year":"2025","journal-title":"Digit. Health"},{"issue":"6","key":"10.1016\/j.intimp.2026.116530_bb0455","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/bioengineering11060606","article-title":"Digital twins for healthcare using wearables","volume":"11","author":"Johnson","year":"2024","journal-title":"Bioengineering"},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0460","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41746-020-00323-1","article-title":"The future of digital health with federated learning","volume":"3","author":"Rieke","year":"2020","journal-title":"npj Digit. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.116530_bb0465","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/ATVBAHA.122.318331","article-title":"Digital twins for predictive, preventive personalized, and participatory treatment of immune-mediated diseases","volume":"43","author":"Benson","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116530_bb0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","article-title":"PAMP s and DAMP s: signal 0s that spur autophagy and immunity","volume":"249","author":"Tang","year":"2012","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2026.116530_bb0475","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116530_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116530_bb0485","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy","volume":"19","author":"Schett","year":"2013","journal-title":"Nat. Med."},{"issue":"10086","key":"10.1016\/j.intimp.2026.116530_bb0490","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.116530_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1647066","article-title":"Innovations in immunotherapy for autoimmune diseases: recent breakthroughs and future directions","volume":"16","author":"Alsayb","year":"2025","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:08:04Z","timestamp":1777129684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926003759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":99,"alternative-id":["S1567576926003759"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116530","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next 5\u00a0years in autoimmunity: predictive diagnostics, immune signatures, and personalized immune therapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116530"}}